Skip to main content

Could Gut Bacteria Help Guide Future MS Treatments?

By MS Buddy ·

Summarized from Advanced science (Weinheim, Baden-Wurttemberg, Germany), Oct 2026 · PubMed · DOI. AI-generated summary. Not medical advice.

Research by Xinyan Han, Jun Guo and 10 colleagues at the Fourth Military Medical University and Airforce Medical Center of PLA in China.

Key Takeaway

In mice with an MS-like illness, a plant compound eased symptoms partly by helping a gut bacterium make a substance that calmed harmful immune activity.

Credibility
Interest
Share:2 min read

What They Found

The researchers studied mice with an illness used to model MS, not people with MS. A plant compound called kurarinone made their illness less severe and increased a gut bacterium called Akkermansia muciniphila. The researchers found that this bacterium was needed for the compound’s protective effect in the mice. The bacterium helped turn tryptophan, a part of food protein, into a substance called IAAld; giving mice IAAld also eased their illness. IAAld appeared to calm immune cells that can mistakenly attack the body by switching on a cell receptor, which works like a signal receiver.

Who Should Care and Why

People with MS and their caregivers may be interested because the study explores how the gut and immune system might work together. Think of gut bacteria as tiny food processors: some of the substances they make may send messages to immune cells. For researchers and healthcare providers, these findings point to a possible new path for studying MS treatments. For now, the findings do not call for a change to your daily care routine. If you are considering a supplement or a change to your MS treatment, talk with your healthcare provider first.

Important Considerations

The treatment was tested in mice with an MS-like illness, so it is not known whether it works or is safe for people with MS. The researchers also studied bacteria and immune cells in the lab, which cannot show what will happen in a person’s body. The study does not show that taking kurarinone, IAAld, or a probiotic will help manage MS symptoms.

AI-generated summary — for informational purposes only, not medical advice

Read the original abstract

Published in Advanced science (Weinheim, Baden-Wurttemberg, Germany) by et al.. Reproduced from the PubMed record.

Multiple sclerosis (MS) is a central nervous system autoimmune disease primarily driven by Th1 and Th17 cells, whose onset and progression are closely associated with gut microbiota. Kurarinone (KU), an active component from Radix Sophora Flavescens, exhibits anti-inflammatory, immunoregulatory and gut microbiota-modulating properties. However, whether KU alleviates MS severity via a gut microbiota-mediated mechanism remains unclear. Here, we demonstrate that KU ameliorates experimental autoimmune encephalomyelitis (EAE)-an animal model of MS-by modulating the gut microbiota, particularly via enriching Akkermansia muciniphila, and A. muciniphila is essential for the protective effects of KU in EAE. Furthermore, KU elevates levels of the tryptophan metabolite indole-3-acetaldehyde (IAAld). IAAld levels are positively correlated with the relative abundance of A. muciniphila and negatively correlated with EAE severity. In vitro, A. muciniphila alone is sufficient to facilitate tryptophan metabolism to produce IAAld. IAAld treatment ameliorates EAE and reduces the frequencies of pathogenic Th1 and Th17 cells in mice. Mechanistically, IAAld activates the aryl hydrocarbon receptor (AhR) and suppresses JAK/STAT signaling, thereby dampening Th1 and Th17 differentiation; these effects are abolished following AhR blockade. Collectively, this study identifies a novel mechanism by which KU mitigates EAE via the gut metabolite IAAld-AhR-immune axis and unveils potential therapeutic targets for MS.

Explore more research

The app

Check out the MS Buddy app

It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play

Related MS research

Brain outline filled with fine, branching nerve fibers on an off-white background.
In relapsing MS, Mavenclad users' thinking scores rose

11/14/2026

In a review of records for 173 people taking Mavenclad for MS, most had no relapses over two years.

Read More
Two views of spinal cord nerve endings, with fewer chemical particles around the endings on the right.
Lab drug cut chemical release in MS-like mouse tissue

11/15/2026

In tissue from mice with an MS-like disease, a lab drug reduced excess chemical release from nerve e

Read More
Two paper paths meet at an open junction, surrounded by layered shapes in muted colors.
When older adults with MS should stop drugs remains unclear

11/15/2026

A survey of 24 Israeli MS specialists found agreement on weighing more than age when treating older

Read More
A winding path links a DNA strand and a partly broken ring in a simple two-color print.
Review explores how immune genes may shape MS damage

11/13/2026

A review compares MS with harmful drug reactions and proposes ways to test how immune genes, lasting

Read More
Two differently colored molecular shapes near immune cells and a myelinated nerve fiber on a pale background.
Review links vitamin D and vitamin A immune signals to MS

11/13/2026

This review examines how vitamin D and vitamin A signals shape immune activity in MS and other disea

Read More
A folded paper shape beside two winding paths with slightly smoother stretches, in muted colors.
In MS-like mice, treatment helped movement and thinking

11/12/2026

In mice with an MS-like disease, a lab-made protein improved movement and thinking. Researchers also

Read More

Not all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.